A Study to Evaluate the Mechanism of Action of Ruxolitinib Cream in Subjects With Vitiligo (TRuE-V MOA)
Clinical trial NCT04896385 · COMPLETED
Trial details
- NCT number
- NCT04896385
- Sponsor
- Incyte Corporation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-23
- Primary completion
- 2022-11-17
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.